ctrl K

Price Alert

Vir Biotechnology Inc. (VIR)

NASDAQ: VIR · Real-Time Price · USD

4.51

0.07 (1.58%)

At close: Aug 15, 2025, 3:59 PM

4.49

-0.43%

After-hours: Aug 15, 2025, 07:24 PM EDT

Vir Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	222.95M	241.58M	848.63M	347.81M
Short-Term Investments	678.05M	1.28B	1.55B	360.33M
Long-Term Investments	190.01M	105.28M	23.93M	201.39M
Other Long-Term Assets	18.42M	18.86M	-228.5M	-87.07M
Receivables	5.1M	n/a	n/a	773.08M
Inventory	n/a	n/a	n/a	8.59M
Other Current Assets	46.98M	65.82M	59.2M	8.59M
Total Current Assets	1.04B	1.59B	2.52B	1.56B
Property-Plant & Equipment	122.86M	167.2M	188.17M	130.05M
Goodwill & Intangibles	25.06M	39.5M	49.69M	50.22M
Total Long-Term Assets	356.36M	330.83M	283.01M	391.45M
Total Assets	1.4B	1.92B	2.8B	1.95B
Account Payables	5.08M	6.33M	6.42M	6.52M
Deferred Revenue	12.65M	64.85M	15.52M	98.21M
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	16.06M	9.35M	7.65M	96.83M
Total Current Liabilities	119.66M	175.41M	511.03M	341.24M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	38.63M	40.22M	32.8M	25.36M
Total Long-Term Liabilities	128.77M	153.42M	213.1M	181.18M
Total Liabilities	248.43M	328.82M	724.13M	522.42M
Total Debt	97.89M	124.54M	127.97M	133.56M
Common Stock	14K	13K	13K	13K
Retained Earnings	-759.78M	-237.82M	377.24M	-138.6M
Comprehensive Income	-1.72M	-815K	-9.12M	-1.1M
Shareholders Equity	1.15B	1.59B	2.08B	1.43B
Total Investments	868.07M	1.39B	1.55B	561.72M